Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moraga Biotechnology Corporation is a regenerative medicine company specializing in the development of adult-derived pluripotent stem cell therapies. The company's proprietary platform focuses on the isolation, purification, and expansion of "Blastomere-Like Stem Cells" (BLSCs), which it claims are totipotent and capable of differentiating into all three germ layers. Moraga's business model includes providing stem cell banking services and developing therapeutic programs for a wide range of conditions, including cardiovascular diseases, neurodegenerative disorders, and orthopedic repairs. Founded by experts in stem cell biology, the company has secured several patents for its unique cell isolation methods and serum-free culture reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moraga Biotechnology.